The healthcare sector is particularly exposed to ongoing legal and political uncertainties regarding Brexit. The senior management of Sanofi and Alliance Pharma have indicated they boosted inventories ahead of the original March deadline as a response. It’s not just about short-term planning though with AstraZeneca’s Chairman, Leif Johansson stating the firm has “been preparing for a no-deal Brexit since the referendum”. British imports of medical products jumped 69.8% year over year in March, including a 99.2% surge from the EU which accounted for 78.5% of British imports. There’s since...